Associations of diabetic neuropathy evaluated by HDN-1000 with glycemic control and other clinical parameters: A observational study
Not Applicable
Completed
- Conditions
- Diabetes
- Registration Number
- JPRN-jRCT1090220277
- Lead Sponsor
- Hidetaka Hamasaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Between January 2015 and October 2016, a total of 740 individuals who had an examination for DN were included.
Exclusion Criteria
Patients younger than 20 years, with other neurological disorders than DN were excluded. Patients who could not undergo an examination for DN because of lower extremity edema and injuries were also excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sural nerve conduction velocity (SNCV) and amplitude (SNAP).
- Secondary Outcome Measures
Name Time Method Blood glucose levels, HbA1c, blood pressure, lipid profile, and indicators of arteriosclerosis such as ABI, TBI, and baPWV.